NOX-E36 First-in-Human (FIH) Study

Clinical trial NCT00976729 · COMPLETED

Trial details

NCT number: NCT00976729
Sponsor: TME Pharma AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Inflammatory Diseases Type 2 Diabetes Mellitus Systemic Lupus Erythematosus

Start date: 2009-05-01
Primary completion: 2009-12-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.